nach oben

Erschienen in:

11.05.2017 | Technical Note

SUV navigator enables rapid [¹⁸F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations

verfasst von: Atsutaka Okizaki, Michihiro Nakayama, Shunta Ishitoya, Kaori Nakajima, Masaaki Yamashina, Tamio Aburano, Koji Takahashi

Erschienen in: Japanese Journal of Radiology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Positron emission tomography (PET) and the maximum standardized uptake value (SUV_max) is a useful technique for assessing malignant tumors. Measurements of SUV_max in multiple lesions per patient frequently require many time-consuming procedures. To address this issue, we designed a novel interface named SUV Navigator (SUVnavi), and the purpose of this study was to investigate its utility.

Materials and methods

We measured SUV_max in 661 lesions from 100 patients with malignant tumors. Diagnoses and SUV_max measurements were made with SUVnavi, 2D, and 3D measurements. SUV measurement accuracy in each method were also evaluated.

Results

The average reduction in time with SUVnavi versus 2D was 53.8% and 3D was 37.5%; time required with SUVnavi was significantly shorter than with 2D and 3D (P < 0.001 and P < 0.001, respectively). The time reduction and lesion number had a positive correlation (P < 0.001 and P < 0.001, respectively). SUV_max agreed with precise SUV_max in all lesions measured with SUVnavi and 3D but in only 466 of 661 lesions (70.5%) measured with 2D.

Conclusion

SUVnavi may be useful for rapid [¹⁸F]-fluorodeoxyglucose positron emission tomography/computed tomography ([¹⁸F]-FDG PET/CT) image interpretation without reducing the accuracy of SUV_max measurement.

Allen-Auerbach M, Weber WA. Measuring response with FDG-PET: methodological aspects. Oncologist. 2009;14(4):369–77.CrossRefPubMed

De Maeseneer DJ, Lambert B, Surmont V, Geboes K, Rottey SW. 18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours. Acta Clin Belg. 2010;65(5):291–9.CrossRefPubMed

Yu L, Tian M, Gao X, Wang D, Qin Y, Geng J. The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma. Acad Radiol. 2012;19(4):427–33.CrossRefPubMed

Nambu A, Kato S, Sato Y, Okuwaki H, Nishikawa K, Saito A, et al. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med. 2009;23(3):269–75.CrossRefPubMed

Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, et al. Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography. Surg Today. 2012;42(10):934–9.CrossRefPubMed

Makino K, Hirai T, Nakamura H, Murakami R, Kitajima M, Shigematsu Y, et al. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med. 2011;25(6):432–8.CrossRefPubMed

Rossi C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, Humbert O, Legouge C, et al. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients. J Nucl Med. 2014;55(4):569–73.CrossRefPubMed

Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47(5):885–95.PubMed

Takeda A, Sanuki N, Fujii H, Yokosuka N, Nishimura S, Aoki Y, et al. Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy. J Thorac Oncol. 2014;9(1):65–73.CrossRefPubMed

10.

Shiono S, Abiko M, Okazaki T, Chiba M, Yabuki H, Sato T. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Eur J Cardiothorac Surg. 2011;40(5):1165–9.PubMed

11.

Kaira K, Endo M, Asakura K, Tsuya A, Nakamura Y, Naito T, et al. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer. Ann Nucl Med. 2010;24(10):697–705.CrossRefPubMed

12.

Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, et al. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2011;71(1):49–54.CrossRefPubMed

13.

Harada S, Sato S, Suzuki E, Okumura Y, Hiraki T, Gobara H, et al. The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation. Acta Med Okayama. 2011;65(6):395–402.PubMed

14.

Lopez Guerra JL, Gladish G, Komaki R, Gomez D, Zhuang Y, Liao Z. Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. J Nucl Med. 2012;53(2):225–33.CrossRefPubMed

15.

Suh C, Kang YK, Roh JL, Kim MR, Kim JS, Huh J, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med. 2008;49(11):1783–9.CrossRefPubMed

16.

Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood. 2011;118(1):37–43.CrossRefPubMed

17.

Karam M, Ata A, Irish K, Feustel PJ, Mottaghy FM, Stroobants SG, et al. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. Nucl Med Commun. 2009;30(10):770–8.CrossRefPubMed

18.

Chihara D, Oki Y, Onoda H, Taji H, Yamamoto K, Tamaki T, et al. High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol. 2011;93(4):502–8.CrossRefPubMed

19.

Maffione AM, Ferretti A, Grassetto G, Bellan E, Capirci C, Chondrogiannis S, et al. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging. 2013;40(6):853–64.CrossRefPubMed

20.

Kong CB, Byun BH, Lim I, Choi CW, Lim SM, Song WS, et al. (1)(8)F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma. Eur J Nucl Med Mol Imaging. 2013;40(5):728–36.CrossRefPubMed

21.

Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999;35(13):1773–82.CrossRefPubMed

22.

Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122s–50s. doi:10.2967/jnumed.108.057307.CrossRefPubMedPubMedCentral

23.

Lee ST, Lawrentschuk N, Scott AM. PET in prostate and bladder tumors. Semin Nucl Med. 2012;42:231–46.CrossRefPubMed

24.

Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274–92.CrossRefPubMed

25.

Shiga T, Morimoto Y, Kubo N, et al. A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity. J Nucl Med. 2009;50:148–55.CrossRefPubMed

Titel: SUV navigator enables rapid [18F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations
verfasst von: Atsutaka Okizaki
Michihiro Nakayama
Shunta Ishitoya
Kaori Nakajima
Masaaki Yamashina
Tamio Aburano
Koji Takahashi
Publikationsdatum: 11.05.2017
Verlag: Springer Japan
Erschienen in: Japanese Journal of Radiology / Ausgabe 7/2017
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI: https://doi.org/10.1007/s11604-017-0645-8

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

SUV navigator enables rapid [¹⁸F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations